We are a scientific leader in dermatologic solutions that recently announced a strategic pivot from pharmaceutical development to begin focusing on the development and commercialization of direct-to-consumer skincare solutions. The Company is currently developing a first-of-its-kind skin renewal product, called the Foundational Treatment, under our Tome skincare brand in the middle of 2026. Visit tomeskincare.com to find more information on our Tome skincare products.
Company Profile
Industry Classifications
Sector:
Manufacturing
Industry:
Pharmaceuticals
NAICS:
Pharmaceutical Preparation Manufacturing (325412)
SIC:
Pharmaceutical Preparations (2834)
Contact Information
Investor Relations
Cliff Mastricola
T: 858-456-7300
cmastricola@dermatarx.com
Company Contact
Dermata Therapeutics, Inc.
3525 Del Mar Heights Rd.
#322
San Diego, CA 92130